bioRxivMolecular BiologyPreprint
A target expression threshold dictates invader defense and autoimmunity by CRISPR-Cas13
Elena VialettoiD, Yanying YuiD, Scott P. CollinsiD, Katharina G. WanderaiD, Lars BarquistiD, Chase L. BeiseliD
Abstract
Immune systems must recognize and clear foreign invaders without eliciting autoimmunity. CRISPR-Cas immune systems in prokaryotes manage this task by following two criteria: extensive guide:target complementarity and a defined target-flanking motif. Here we report an additional requirement for RNA-targeting CRISPR-Cas13 systems: expression of the target transcript exceeding a threshold. This finding is based on targeting endogenous non-essential transcripts, which rarely elicited dormancy through collateral RNA degradation. Instead, eliciting dormancy required over-expressing targeted transcripts above a threshold. A genome-wide screen confirmed target expression levels as the principal determinant of cytotoxic autoimmunity and revealed that the threshold shifts with the guide:target pair. This expression threshold ensured defense against a lytic bacteriophage yet allowed tolerance of a targeted beneficial gene expressed from an invading plasmid. These findings establish target expression levels as a third criterion for immune activation by RNA-targeting CRISPR-Cas systems, buffering against autoimmunity and distinguishing pathogenic and benign invaders. HIGHLIGHTSO_LICas13-induced dormancy requires RNA target levels to exceed an expression threshold C_LIO_LIThe expression threshold can prevent cytotoxic self-targeting for endogenous transcripts C_LIO_LIThe threshold shifts depending on the CRISPR RNA guide:target pair C_LIO_LIThe threshold allows cells to distinguish pathogenic and benign infections C_LI
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Degenerated CRISPRs widely regulate Cas expression to balance immunity and cost
- A natural single-guide RNA repurposes Cas9 to autoregulate CRISPR-Cas expression
R. E. Workman, T. Pammi, … J. W. Modell·bioRxiv·May 21, 2020
- CRISPR-Cas supervises diverse anti-phage defense systems
- The Cas10 nuclease activity relieves host dormancy to facilitate spacer acquisition and retention during type III-A CRISPR immunity
N. Aviram, A. Shilton, … L. A. Marraffini·bioRxiv·Feb 11, 2024
- Dynamics of Cas10 Govern Discrimination between Self and Nonself in Type III CRISPR-Cas Immunity
- Heterologous autoimmunity and prokaryotic immune defense
H. Chen, A. Mayer, V. Balasubramanian·bioRxiv·Jan 4, 2021